Best Seller
A single-molecule dual GIP and GLP-1 receptor agonist. Supplied as a high-purity lyophilized powder for metabolic and incretin-pathway research.
Tirzepatide is a synthetic 39-amino-acid peptide engineered to activate both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors from a single molecule. In research settings it is studied as a tool compound for investigating incretin signaling, glucose homeostasis and energy-balance pathways.
Each vial is synthesized to a high standard, lyophilized for stability and released with a batch certificate of analysis. This product is sold strictly for in-vitro and laboratory research; it is not a drug, supplement or food.
No reviews have been published for this product yet.